ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Otonomy Inc

Otonomy Inc (OTIC)

0.077
0.00
(0.00%)
마감 29 11월 6:00AM
0.00
0.00
(0.00%)
시간외 거래: -

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
0.077
매수가
0.0757
매도가
0.0777
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
0.077
개장가
-
최근 거래 시간
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

OTIC 최신 뉴스

Otonomy Announces Change in Stock Exchange Listing

SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq...

Otonomy Provides Corporate Update

SAN DIEGO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that the company’s board of directors, after considering strategic options, has approved and adopted a...

Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported...

Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss

Higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baselineLack of activity compared to 0.3 mg dose evaluated in prior studies may be due to a...

Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus

OTO-313 demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepointsCompany to discontinue development of OTO-313 and implement other...

Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Top-line results for OTO-313 Phase 2 trial in tinnitus expected in August 2022; patient enrollment completed for clinical safety evaluation of higher and bilateral dosing of OTO-313 with top-line...

Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update

SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...

Otonomy to Participate in the H.C. Wainwright Global Investment Conference

SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its...

Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting

SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...

Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update

Positive top-line results announced for OTO-413 Phase 2a in hearing loss; enrollment ongoing for higher dose evaluationOTO-313 Phase 2 trial in tinnitus fully enrolled with top-line results...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
VCIGVCI Global Ltd
US$ 4.1092
(129.56%)
257.58M
IDAIT Stamp Inc
US$ 0.835
(128.77%)
374.4M
WAITop KingWin Ltd
US$ 0.43
(79.17%)
121.92M
HWHHWH International Inc
US$ 0.918
(62.48%)
32.27M
PROCProcaps Group SA
US$ 2.149
(58.01%)
211.74k
PGHLPrimega Group Holdings Ltd
US$ 1.6455
(-98.47%)
43.27M
OTLKOutlook Therapeutics Inc
US$ 1.695
(-65.34%)
62.28M
IMGCIMG Inc
US$ 0.8831
(-44.81%)
5.34M
KDLYKindly MD Inc
US$ 1.075
(-43.12%)
3.54M
HAOHaoxi Health Technology Ltd
US$ 0.13
(-36.59%)
37.42M
IDAIT Stamp Inc
US$ 0.835
(128.77%)
374.4M
VCIGVCI Global Ltd
US$ 4.1092
(129.56%)
257.58M
NVDANVIDIA Corporation
US$ 135.34
(-1.15%)
226.41M
WAITop KingWin Ltd
US$ 0.43
(79.17%)
121.92M
MARAMARA Holdings Inc
US$ 26.915
(7.79%)
87.94M
ilovetech ilovetech 5 분 전
pqr - I too appreciate the feedback. The Judge had found 30 * transactions likely to be spoofing episodes. He asked Posner to use those, as a base from which to formulate loss causation. I believe she came back with some 293 pages and Dr. Milligrams Report provided. If as you say, the law hasn't cau
NWBO
Bmrboy Bmrboy 11 분 전
OTC (DREM) - thanks. I've watched it recently and have been in this one for awhile.
Ronin Ronin 11 분 전
Remember when Anheiser Busch was supposed to be the breakout news for APRU in 2018? Hype from that news was supposed to put APRU on the moon. But that never happened, So what’s the gimmick this time? More empty pie-in-the-sky promises so the stock can further be diluted?

Apple Rush, I
APRU
TomD2046 TomD2046 12 분 전
Did you pay to see that from delaware sos? Any chance you could share here or on twitter?
FBEC
Konaploinks Konaploinks 14 분 전
HMB. YEP. With Quantum + A I advancing as it is we might be star travelers. I was one back in the 60’s a little ahead of my time lol So I already have some experience. lol Don’t tell my kids that. But seriously. The future is right before our eyes. So many advances will happen at warp speed soon an
IONQ
Richie R Richie R 17 분 전
Any black Friday announcement????
threewheeler threewheeler 17 분 전
WPFH well just maybe, fingers crossed, having a 2 yr hold on our shares will make everyone the SOLIaires we thought 5 yrs ago
WPFH
MrSmith101 MrSmith101 21 분 전
Thank you for acknowledging this is factual. People mislead that this stock was a great deal at .079 and continue to do the same as it has dropped, and dropped, and dropped.
GRST
MrSmith101 MrSmith101 21 분 전
Thank you for acknowledging this is factual. People mislead that this stock was a great deal at .079 and continue to do the same as it has dropped, and dropped, and dropped.
GRST
georgejjl georgejjl 22 분 전
Tomorrow November 29, 2024 the stock market will be open only 4 hours. That means that there will be only 4 hours to buy AVXL shares tomorrow.

Good luck and GOD bless,
AVXL
CrossFireTrader CrossFireTrader 23 분 전
https://store.veemost.com
GDVM
DTGoody DTGoody 25 분 전
That would be a dream come true for us. I am also liking the fact that we may get spin off shares of another NASDAQ stock according to this on the last page of the November Quarterly Report:

https://www.otcmarkets.com/otcapi/company/financial-report/417128/content

NOTE
WPFH
StayHumble StayHumble 26 분 전
✅ 7/7/23 $HCMC entered a 💹 VapePatent LicensingAgreement 💹

$HCMC grants to licensee a non-exclusive right & license to make|use|offer|sell, sell,& import licensed products in the USA. Licensee will pay based on net sales of all products
https://dd7pmep5szm19.c
HCMC
threewheeler threewheeler 26 분 전
agreed but way better than we were 48 hrs ago SOLIanaires
AZrealestate AZrealestate 26 분 전
Just read that Bill Ackman will be involved with the Department of Gov Efficiency. Is Bill still holding his FNMA position? I've been out of the loop lately.
FNMA
StayHumble StayHumble 27 분 전
✅wow $1BILLION BUYSBACK✅All $HCMC Shares! D0LLARS$$$ wow✅
HCMC
Dodger1 Dodger1 28 분 전
Go $AABB
AABB
littlejohn littlejohn 28 분 전
Yes, common sense, there aren't mice out there

creating all the trading volume in the

markets each day...

Big fundie traders are trading everyday...

And have pay bases on gains...

Friday is month end, so booking everything
SMCI
CrossFireTrader CrossFireTrader 29 분 전
I'd dump if was you !!! get out while you can,  throw a block of 5M shares up there AON and I'll get you out. 
GDVM
bwrbad bwrbad 29 분 전
Its the top scam of all the other QC scam. enjoy ride but go to safety before quake.
QUBT
Kool Aid Man Kool Aid Man 30 분 전
"Hamilton Associates LLC" --apparently a non-existent company that supposedly owns/owned "$18 million in land and buildings"-- was supposedly rolled into (aka "included") in Bloxcross (a private company) which Park said he acquired a "majority stake" in.

(Page 22: https://www.otcmar
SPZI
StayHumble StayHumble 30 분 전
inCourtUnderOath✅D0E tried Crying V.$DBMM+Mgmt✅(D0H! Br. at 25-28.)

$DBMM has obtained resources to complete the re-audit, bring the Company current, & continue its timely filings,

DOE once again rejects the Law Judge’s analysis and conclusion that
DBMM
ilovetech ilovetech 31 분 전
According to Gemini: Yes, regulators do find gene and cell therapies more challenging to review than tablet-based medications. Here's why:
Novelty and Complexity: Gene and cell therapies utilize cutting-edge techniques, making their mechanisms of action more intricate.
Long-Term Effect
NWBO
skitahoe skitahoe 31 분 전
I agree, and that's the biggest reason the 7 MM's won't want to open their books.

In reality, the SEC has pretty much been hands off when it comes to the Pinks and OTC, but if the books are open and they can't deny what's happening, they could take an interest. That's why I feel so c
NWBO
dcwisc dcwisc 32 분 전
A Permitted Mill
northbay-resources.com/portfolio/bishop-gold-mill/
NBRI

최근 히스토리

Delayed Upgrade Clock